Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: sorafenib
What it is used for
Hepatocellular carcinoma. NEXAVAR is indicated for the treatment of patients with advanced hepatocellular carcinoma (HCC). Renal cell carcinoma. NEXAVAR is indicated for the treatment of patients with advanced renal cell carcinoma (RCC). Differentiated Thyroid carcinoma. NEXAVAR is indicated for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Red, round, biconvex, film-coated tablets marked with BAYER cross on one side and "200" on the reverse.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient sorafenib
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Genetic testing for cancer information | myVMC
Inherited genetic mutations increase the risk of certain cancers. Genetic testing is used to group cancers and develop new targeted cancer therapies.
Read more on myVMC – Virtual Medical Centre website
Oral targeted therapy for cancer | Issue 5 | Volume 38 | Australian Prescriber
Oral targeted therapies are increasingly being used to treat cancer. They work by interfering with specific molecules or pathways involved in tumour...
Read more on Australian Prescriber website